Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Clinical Microbiology

• Publication date

  1987-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jcm.25.3.559-562.1987PMID 3571460PMCID PMC265990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.

  1986cited by this paper
• Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection

  1986cited by this paper
• Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine

  1986influential reference
• Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

  1985cited by this paper
• Comparison of long‐term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine

  1985cited by this paper
• Evaluation of Thirty-One Mouse Monoclonal Antibodies to Human IgG Epitopes

  1984cited by this paper
• Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus

  1983cited by this paper
• Immune responses in serum and respiratory secretions following vaccination with a live cold‐recombinant (cr35) and inactivated a/ussr/77 (h1n1) influenza virus vaccine

  1983cited by this paper
• Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines

  1982influential reference
• IgA subclasses in various secretions and in serum.

  1982cited by this paper
• Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses

  1981cited by this paper
• Mucosal immunology.

  1980cited by this paper
• Secretory immunological response in infants and children to parainfluenza virus types 1 and 2

  1980cited by this paper
• Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection

  1979cited by this paper
• The immunologic response to infection with respiratory syncytial virus in infants.

  1978cited by this paper
• Enteric Immunization with Live Adenovirus Type 21 Vaccine II. Systemic and Local Immune Responses Following Immunization

  1972cited by this paper
• Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome.

  1972cited by this paper
• Immunoglobulin E in Immunologic Deficiency Diseases

  1972cited by this paper
• Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.

  1971cited by this paper
• Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man.

  1970cited by this paper
• Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine.

  1969cited by this paper
• Antibody response in respiratory secretions of volunteers given live and dead influenza virus.

  1968cited by this paper

• Cytomegalovirus‐Based Viral Vectors Elicit Robust Systemic and Tissue‐Resident Immune Response Against SARS‐CoV‐2 Antigens

  2026cites this paper
• Local B-cell immunity and durable memory following live-attenuated influenza intranasal vaccination of humans

  2025cites this paper
• Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice.

  2024cites this paper
• Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques

  2024cites this paper
• Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients

  2024influential citation
• Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters

  2024cites this paper
• Olfactory immunology: the missing piece in airway and CNS defence

  2023cites this paper
• Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents

  2023cites this paper
• Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques

  2023cites this paper
• Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment

  2023cites this paper
• Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2

  2022cites this paper
• AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

  2022cites this paper
• Instructing durable humoral immunity for COVID-19 and other vaccinable diseases

  2022cites this paper
• Airway immune responses to COVID-19 vaccination in COPD patients and healthy subjects

  2022cites this paper
• Mucosal plasma cells are required to protect the upper airway and brain from infection.

  2022cites this paper
• AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

  2022cites this paper
• Bacterial Vaccines

  2021cites this paper
• A 250‐kDa glycoprotein of Naegleria fowleri induces protection and modifies the expression of α4β1 and LFA‐1 on T and B lymphocytes in mouse meningitis model

  2021cites this paper
• Inducing Quality Immune Response to Respiratory Viruses May Not Be a Simple Task

  2021cites this paper
• Infant rhesus macaques as a non-human primate model of Bordetella pertussis infection

  2021cites this paper
• Identification of Immunogenic Antigens of Naegleria fowleri Adjuvanted by Cholera Toxin

  2020cites this paper
• Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans

  2020cites this paper
• Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections

  2020cites this paper
• Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin

  2019cites this paper
• How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions

  2019cites this paper
• The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine

  2019cites this paper
• IgA: Structure, Function, and Developability

  2019cites this paper
• FcγRIII stimulation breaks the tolerance of human nasal epithelial cells to bacteria through cross-talk with TLR4

  2019cites this paper
• New antibody-based prevention and treatment options for influenza.

  2019cites this paper
• Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre

  2017cites this paper
• Enhancement of Avian Influenza Virus vaccines in chickens through identification and application of novel mucosal adjuvants

  2016cites this paper
• Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers

  2016cites this paper
• Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays

  2016cites this paper
• Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses

  2016cites this paper
• Seasonal influenza vaccines and hurdles to mutual protection.

  2016cites this paper
• Direct Administration in the Respiratory Tract Improves Efficacy of Broadly Neutralizing Anti-Influenza Virus Monoclonal Antibodies

  2015cites this paper
• Prospects for broadly protective influenza vaccines.

  2015cites this paper
• Prospects for Broadly Protective Influenza Vaccines.

  2015cites this paper
• Intranasal coadministration of Cholera toxin with amoeba lysates modulates the secretion of IgA and IgG antibodies, production of cytokines and expression of pIgR in the nasal cavity of mice in the model of Naegleria fowleri meningoencephalitis.

  2014cites this paper
• Kinetics of influenza A virus nucleoprotein antibody (IgM, IgA, and IgG) in serum and oral fluid specimens from pigs infected under experimental conditions.

  2013cites this paper
• Influenza A virus antibody in porcine oral fluid and its diagnostic applications

  2013cites this paper
• Immunological assessment of influenza vaccines and immune correlates of protection

  2013cites this paper
• Targeting the Highly Conserved Sequences in Influenza A Virus

  2013cites this paper
• The Contribution of Systemic and Pulmonary Immune Effectors to Vaccine-Induced Protection from H5N1 Influenza Virus Infection

  2012cites this paper
• Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine.

  2012cites this paper
• Comparison of the Cross-Reactive Anti-Influenza Neutralizing Activity of Polymeric and Monomeric IgA Monoclonal Antibodies

  2012cites this paper
• Kinetics of the avian influenza-specific humoral responses in lung are indicative of local antibody production.

  2012cites this paper
• Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

  2011cites this paper
• Influenza Viruses, Including Avian Influenza and Swine Influenza

  2010cites this paper
• GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates

  2010cites this paper
• An Adjuvant for the Induction of Potent, Protective Humoral Responses to an H5N1 Influenza Virus Vaccine with Antigen-Sparing Effect in Mice

  2010cites this paper
• Interactions of foot-and-mouth disease virus with cells in organised lymphoid tissue influence innate and adaptive immune responses

  2009cites this paper
• Immunization with Cry1Ac from Bacillus Thuringiensis Increases Intestinal IgG Response and Induces the Expression of FcRn in the Intestinal Epithelium of Adult Mice

  2009cites this paper
• Prolonged Protection against Intranasal Challenge with Influenza Virus following Systemic Immunization or Combinations of Mucosal and Systemic Immunizations with a Heat-Labile Toxin Mutant

  2009cites this paper
• Breast-Feeding Is Associated With a Reduced Frequency of Acute Otitis Media and High Serum Antibody Levels Against NTHi and Outer Membrane Protein Vaccine Antigen Candidate P6

  2009cites this paper
• Mucosal and systemic antibody responses induced by virus-like particles

  2008cites this paper
• Efficient induction of mucosal and systemic immune responses by virus‐like particles administered intranasally: implications for vaccine design

  2008cites this paper
• Immunological studies of cold-adapted influenza vaccine viruses in mice

  2008cites this paper
• Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse

  2007cites this paper
• Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers

  2006cites this paper
• Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects.

  2006cites this paper
• Common Respiratory Viruses and Pulmonary Mucosal Immunology

  2006cites this paper
• Synthesis and Characterization of Lipooligosaccharide-Based Conjugate Vaccines for Serotype B Moraxella catarrhalis

  2005cites this paper
• Chapter 43 – Mucosal Immunity to Viruses

  2005cites this paper
• The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus

  2005cites this paper
• Protective effect of serum antibody on respiratory infection of influenza C virus in rats

  2005cites this paper
• Comparison of protective effects of serum antibody on respiratory and systemic infection of Sendai virus in mice

  2005cites this paper
• Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract1

  2004influential citation
• Influenza: current evidence and informed predictions

  2004cites this paper
• Mucosal Vaccine Made from Live, Recombinant Lactococcus lactis Protects Mice against Pharyngeal Infection with Streptococcus pyogenes

  2004cites this paper
• This information is current as Respiratory Tract Influenza Viral Infection in the Murine Role of IgA versus IgG in the Control of and

  2004influential citation
• Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.

  2003cites this paper
• Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

  2002cites this paper
• Protection Against Influenza Virus Infection in Polymeric Ig Receptor Knockout Mice Immunized Intranasally with Adjuvant-Combined Vaccines

  2002cites this paper
• Differences between the Large and Small Intestine in the Immunodominant Amoebic Proteins Recognized by IgG and IgA Antibodies in BALB/c Mice

  2002cites this paper
• Mucosal immunity and viral infections

  2001cites this paper
• Role of Immunoglobulin A in Protection against Reovirus Entry into Murine Peyer's Patches

  2001cites this paper
• Intranasal, rectal and intraperitoneal immunization with protoxin Cry1Ac from Bacillus thuringiensis induces compartmentalized serum, intestinal, vaginal and pulmonary immune responses in Balb/c mice.

  2000cites this paper
• Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model.

  2000cites this paper
• Systemic and Mucosal Isotype-Specific Antibody Responses in Pigs to Experimental Influenza Virus Infection

  2000cites this paper
• Immunoglobulins in Nasal Secretions of Healthy Humans: Structural Integrity of Secretory Immunoglobulin A1 (IgA1) and Occurrence of Neutralizing Antibodies to IgA1 Proteases of Nasal Bacteria

  2000cites this paper
• Mucosal and systemic immunity against poliovirus in mice transgenic for the poliovirus receptor: the poliovirus receptor is necessary for a virus-specific mucosal IgA response.

  2000cites this paper
• A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice.

  1999cites this paper
• Interactions of monoclonal antibodies with an influenza A virus

  1999cites this paper
• Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.

  1998cites this paper
• Cervical antibody responses to a herpes simplex virus type 2 glycoprotein subunit vaccine.

  1998cites this paper
• Induction of Immunity in the Respiratory Tract and Protection from Bovine Herpes virus Type 1 Infection by Different Routes of Immunization with Recombinant Adenovirus

  1998cites this paper
• The specificity patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions.

  1998cites this paper
• Synthesis and Characterization of Lipooligosaccharide-Based Conjugates as Vaccine Candidates forMoraxella (Branhamella)catarrhalis

  1998cites this paper
• The Specificity Patterns of Human Immunoglobulin G Antibodies in Serum Differ from Those in Autologous Secretions

  1998cites this paper
• The bovine parainfluenza virus type-3 (BPIV-3) hemagglutinin/neuraminidase glycoprotein expressed in baculovirus protects calves against experimental BPIV-3 challenge.

  1997cites this paper
• Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses.

  1997cites this paper
• Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins

  1996cites this paper
• Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit

  1996cites this paper
• High Affinity Serum‐Derived Fab Fragments as Another Source of Antibodies in the Gut Lumen of both Neonates and Adults

  1996cites this paper
• toxin B subunit . with a bacterial protein antigen and the Cholera responses in monkeys immunized intranasally Salivary , nasal , genital , and systemic antibody

  1996cites this paper
• Hypothesis: how licensed vaccines confer protective immunity.

  1996cites this paper
• Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults

  1996cites this paper
• Systemic and Secretory Humoral Immunity in the Normal Human Vaginal Tract

  1995cites this paper
• Detection of foot-and-mouth disease virus-infected cattle by assessment of antibody response in oropharyngeal fluids

  1995cites this paper